Evidence map›Paper›PMID 41834420›Full record

ArticleAngewandte Chemie (International ed. in English)2026

Rh-Catalyzed Chemodivergent Parallel Kinetic Resolution and Desymmetrization of Enynes and Dienynes with Acrylamides.

Shintaro Hamada, Julong Jiang, Yu Sato, Takashi Yamazaki, Satoshi Maeda, Ken Tanaka

Abstract read
In one paragraph

Article in Angewandte Chemie (International ed. in English), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Shintaro HamadaDepartment of Chemical Science and Engineering, Institute of Science Tokyo, Meguro-ku, Tokyo, Japan.
Julong JiangInstitute for Chemical Reaction Design and Discovery (WPI-ICReDD), Hokkaido University, Sapporo, Hokkaido, Japan.ORCID https://orcid.org/0000-0002-2357-1127
Yu SatoDepartment of Chemical Science and Engineering, Institute of Science Tokyo, Meguro-ku, Tokyo, Japan.
Takashi YamazakiDepartment of Chemical Science and Engineering, Institute of Science Tokyo, Meguro-ku, Tokyo, Japan.
Satoshi MaedaInstitute for Chemical Reaction Design and Discovery (WPI-ICReDD), Hokkaido University, Sapporo, Hokkaido, Japan.ORCID https://orcid.org/0000-0001-8822-1147
Ken TanakaDepartment of Chemical Science and Engineering, Institute of Science Tokyo, Meguro-ku, Tokyo, Japan.ORCID https://orcid.org/0000-0003-0534-7559

Funding

JSPS JP24H00005JST SPRING JPMJSP2180The Uehara Memorial Foundation
6 · The paper itself

Abstract

Catalytic enantioselective synthesis of structurally diverse 3D molecules remains a central challenge in organic chemistry. Intermolecular chemodivergent parallel kinetic resolution (PKR) of racemic substrates through C─C bond formation using a single catalyst to yield distinct products is rare. Here, we report Rh-catalyzed chemodivergent PKR of racemic 1,6-enynes with α-fluoroacrylamides or mixtures of different acrylamides, proceeding via [2+2+2] cycloaddition and C-H alkylation to afford structurally and stereochemically distinct products with high selectivity under mild conditions. Additionally, substituent-dependent enantioselective desymmetrization of symmetric dienynes was achieved. Computational studies revealed that, depending on the stereochemistry of the 1,6-enyne, steric repulsion between the ligand and the enyne favors a compact C-H activation transition state, whereas its absence favors a C═C insertion transition state involving a smaller bond dissociation energy. These findings establish a versatile catalytic platform for the selective generation of 3D molecular complexity, advancing diversity-oriented synthesis from racemic or symmetric precursors.

Indexed as

3D moleculesdesymmetrizationenynesfluorinated tertiary stereocenterparallel kinetic resolutionrhodium

Identifiers

PMID41834420
PMCPMC13098305

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.